After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ESPR belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Esperion Therapeutics Inc is $939.52M. A total of 12.35 million shares were traded on the day, compared to an average of 6.95M shares.
In the most recent transaction, Koenig Sheldon L. sold 48,244 shares of ESPR for 3.67 per share on Dec 17 ’25. After the transaction, the President and CEO now owns 1,470,587 company shares. In a previous transaction on Dec 17 ’25, Halladay Benjamin sold 7,337 shares at 3.67 per share. ESPR shares that Chief Financial Officer owns now total 467,525.
Among the insiders who sold shares, Looker Benjamin disposed of 6,517 shares on Dec 17 ’25 at a per-share price of $3.67. This resulted in the General Counsel holding 385,905 shares of ESPR after the transaction. In another insider transaction, Koenig Sheldon L. bought 48,244 shares at $3.67 per share on Dec 17 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ESPR has a high of $4.13 and a low of $0.69.
As of this writing, ESPR has an earnings estimate of $0.28 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $0.53 per share and a lower estimate of -$0.03. The company reported an EPS of -$0.1 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$2.20, while its Total Shareholder’s Equity was -$196.94M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.11.
